Event Details
- Location: Alderley Park, Cheshire
- Date: Wednesday 27th September 2017
3.45pm | Registration |
4pm | Welcome from the Chair ELAINE EVANS, Chair, Pharmaceutical Licensing Group UK |
4.05pm | The Pharma Industry Deal Landscape - Deal trends - licensing v M&A, structures, financials, development status, therapeutic areas JILL OGDEN, Medius Associates |
4.25pm | What Big Pharma is Looking For - a Business Development Perspective - Finding the right opportunities, therapeutics areas, development status, preferred deal structures, due diligence issues KAY TAIT, Transaction Director, Business Development Operations, AstraZeneca |
4.45pm | Key Learnings from the Biotech 'Coal Face' - Deal structures and strategies to build maximal value IAN NICHOLSON, CEO, F2G/ Operating Partner, Advent Life Sciences |
5.05pm | Developing Strategies for Optimal Licensing Deal Structures - Thinking into the Future JANET KNOWLES, HGF Law |
5.25pm | How Public Markets View the Biotech Sector HITESH THAKRAR, Partner, Syncona Investment Management |
5.45pm | Networking Reception |
6.30pm | CLOSE |
Alderley Park Conference Centre
Alderley Edge
Cheshire
SK10 4TG